ΣΠΟΥΔΕΣ ΚΑΙ ΣΤΟΙΧΕΙΑ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΔΡΑΣΤΗΡΙΟΤΗΤΑΣ

Transcript

1 Βασίλειος Βαργεμέζης Καθηγητής Νεφρολογίας ΔΠΘ Δ/ντής Παν. Νεφρολογικής Κλινικής ΠΓΝΑ ΣΠΟΥΔΕΣ ΚΑΙ ΣΤΟΙΧΕΙΑ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΔΡΑΣΤΗΡΙΟΤΗΤΑΣ 1975 Ιατρική Σχολή Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης 1979 Ειδικότητα Εσωτερικής Παθολογίας Ιατρική Σχολή ΑΠΘ 1981 Διδακτορική Διατριβή Ιατρική Σχολή ΑΠΘ 1984 Ειδικότητα Νεφρολογίας Ιατρική Σχολή ΑΠΘ Ειδική Εκπαίδευση- Μετεκπαίδευση: Συνεχής Φορητή Περιτοναϊκή Κάθαρση Μεταμόσχευση Νεφρού Ξένες γλώσσες: Αγγλικά- Ιταλικά 1985 Επίκουρος Καθηγητής Νεφρολογίας ΔΠΘ 1989 Αναπληρωτής Καθηγητής Νεφρολογίας ΔΠΘ 1993 Καθηγητής Νεφρολογίας ΔΠΘ 1987 μέχρι και σήμερα Διευθυντής Πανεπιστημιακής Νεφρολογικής Κλινικής ΔΠΘ Υπεύθυνος λειτουργίας και κλινικού έργου της Πανεπιστημιακής Νεφρολογικής Κλινικής, των Μονάδων Αιμοκάθαρσης, Περιτοναϊκής Κάθαρσης, Πλασμαφαίρεσης και των εργαστηρίων Ανοσοϊστοχημείας - Ιστοσυμβατότητας Νεφρού και Παθοφυσιολογίας Νεφρού- Μεταβολικών Νοσημάτων Ερευνητικά και Διδακτικά ενδιαφέροντα Έρευνα και διδασκαλία σε προπτυχιακό και μεταπτυχιακό επίπεδο Διδασκαλία: -Νεφρολογία: προπτυχιακό μάθημα 5ου έτους σπουδών, Εαρινού εξαμήνου Τμήματος Ιατρικής -Εκπαίδευση ειδικευομένων ιατρών στην Νεφρολογία (6 θέσεις ειδικευομένων για πλήρη 4ετή ειδίκευση) -Επιβλέπον Καθηγητής και μέλος Συμβουλευτικών και Εξεταστικών επιτροπών Διδακτορικών Διατριβών - Οργάνωση Σεμιναρίων Συνεχιζόμενης Εκπαίδευσης στη Νεφρολογία Ερευνητικό έργο: -Με αντικείμενο την κλινική νεφρολογία, περιτοναϊκή κάθαρση, αιμοκάθαρση, αναιμία -Με αντικείμενο την ιατρική εκπαίδευση -Στα πλαίσια ευρωπαϊκών πολυκεντρικών μελετών με συμμετοχή στις κεντρικές επιτροπές αποφάσεων (steering committee) -Ανάπτυξη και εφαρμογή τηλεματικής υπηρεσίας για την κατ οίκον παρακολούθηση ασθενών

2 που υποβάλλονται σε περιτοναϊκή κάθαρση. -Ανάλυση χώρου και απαιτήσεων για την κατ οίκον υποστήριξη περιτοναϊκής κάθαρσης -Έρευνα, εφαρμογή και διδασκαλία μεθόδων αξιολόγησης τηλεματικών υπηρεσιών για την κατ οίκον φροντίδα ασθενών Μέλος Επιστημονικών Επιτροπών Αναπληρωτής Πρόεδρος στο Τμήμα Μοριακής Βιολογίας και Γενετικής του ΔΠΘ Εκπρόσωπος του ΔΠΘ στην ένωση των Πανεπιστημίων της Μεσογείου Community of Mediterranean Universities ( CUM) Διευθυντής Τομέα Γενικής Παθολογίας ΔΠΘ Πρόεδρος της επιτροπής Προγράμματος Σπουδών της Ιατρικής Σχολής του ΔΠΘ μέχρι και σήμερα 2003 Πρόεδρος Επιστημονικού Συμβουλίου ΠΓΝΑ Μέλος της επιτροπής διασύνδεσης της CUM με την ένωση των Πανεπιστημίων της Μαύρης Θάλασσας (Black Sea University Foundation) Μέλος της Επιτροπής Ερευνών του ΔΠΘ 2004 μέχρι και σήμερα Μέλος της επιτροπής Προγράμματος Σπουδών της Ιατρικής Σχολής του ΔΠΘ 2005 μέχρι και σήμερα Υπεύθυνος Γραφείου Εκπαίδευσης Ιατρικού Τμήματος ΔΠΘ 2006 μέχρι και σήμερα Μέλος της Επιτροπής Ηθικής και Δεοντολογίας ΔΠΘ 2007 μέχρι και σήμερα 2007 μέχρι και σήμερα Πρόεδρος Επιτροπής Εκπαίδευσης Ελληνικής Νεφρολογικής Εταιρείας Πρόεδρος Επιστημονικής Επιτροπής των Συνεδρίων και Εκπαιδευτικών Σεμιναρίων της Ελληνικής Νεφρολογικής Εταιρείας 2007 Μέλος Επιτροπής Σύνταξης Κώδικα Ηθικής και Δεοντολογίας ΔΠΘ 2008 Μέλος της Επιτροπής Σύνταξης Προτάσεων Προγραμματισμού Τμήματος Ιατρικής του 4ετούς Ακαδημαϊκού - Αναπτυξιακού προγράμματος ΔΠΘ 2008 μέχρι και σήμερα Μέλος 7μελούς Ομάδας Εσωτερικής Αξιολόγησης, Τμήμα Ιατρικής, ΔΠΘ 2007 Μέλος της Επιστημονικής Επιτροπής της Ειδικής Προγράμματος Special Track on Technology Enhanced Learning in Medical Education στα πλαίσια του Διεθνούς Συνεδρίου CBMS 2007: The 20th IEEE International Symposium on Computer-Based Medical Systems, Maribor, Slovenia, June 20-22, μέχρι και σήμερα Πρόεδρος Οργανωτικής Επιτροπής περισσότερων από 10 Εκπαιδευτικών Σεμιναρίων με διεθνή συμμετοχή Μέλος Επιστημονικών Εταιρειών Πρόεδρος Ελληνικής Νεφρολογικής Εταιρείας (ΕΝΕ)

3 European Renal Association /European Dialysis Transplant Association International Society of Peritoneal Dialysis Κριτής σε Επιστημονικά Περιοδικά και Συνέδρια Ελληνική Νεφρολογία Nature Clinical Practice Nephrology Renal Failure Nephrology (Carlton) Nephron Clinical Practice Συμμετοχή σε Επιστημονικές Επιτροπές Διεθνών Κλινικών Μελετών Phase II Study ΒΑ Steering Committee member Roche Hellas Ανοιχτή, πολυκεντρική μελέτη (Φάσης ΙΙ) πολλαπλών δόσεων για τη διερεύνηση της αποτελσματικότητας και ασφάλειας υποδόριων ενέσεων RO χορηγούμενων σε διαφορετικά χρονικά διαστήματα σε ασθενείς με χρόνια αναιμία νεφρικής αιτιολογίας που υποβάλλονται σε αιμοκάθαρση. ΚΩΔΙΚΟΣ ΕΓΚΡΙΣΗΣ ΕΟΦ: Αα-ΚΔ-70/01 Phase III Study BA16736 Steering Committee member, Roche Hellas Ανοιχτή, πολυκεντρική μελέτη (Φάσης ΙΙΙ) της αποτελεσματικότητας των υποδορίων ενέσεων ερυθροποιητίνης βήτα σε ασθενείς με αναιμία λόγω χρόνιας νεφρικής ανεπάρκειας που υποβάλλονται σε περιτοναϊκή κάθαρση, και οι οποίοι μεταβαίνουν από προηγούμενο δοσολογικό σχήμα δύο έως τριών ενέσεων την εβδομάδα σε σχήμα μιας ένεσης την εβδομάδα ή από προηγούμενο δοσολογικό σχήμα μιας ένεσης της εβδομάδας σε σχήμα μιας ένεσης κάθε δύο εβδομάδες. ΚΩΔΙΚΟΣ ΕΓΚΡΙΣΗΣ ΕΟΦ: Αα-ΚΔ-4296 MAP 5/2006 Managing Mineral Metabolism: Advances in Practice (MAP).SHIRE Ερευνητικά έργα: 1. «ΠΕΡΚΑ Κατ Οίκον Υποστήριξη Περιτοναϊκής Κάθαρσης», Χρηματοδότηση: Επιχειρησιακού Προγράμματος Ανατολικής Μακεδονίας Θράκης «Κοινοπραξίες Έρευνας και Τεχνολογικής Ανάπτυξης σε τομείς Εθνικής Προτεραιότητας», Διάρκεια: , Επιστημονικός Υπεύθυνος 2. Αναμόρφωση Προπτυχιακού Προγράμματος Σπουδών Τμήματος Ιατρικής ΔΠΘ- ΕΠΕΑΕΚ ΙΙ Πράξεις ΕΚΤ για Αναμόρφωση Προπτυχιακών Προγραμμάτων Σπουδών, Υπουργείο Εθνικής Παιδείας και Θρησκευμάτων. Διάρκεια: , Επιστημονικός Υπεύθυνος 3. Εξοπλισμός για Υποστήριξη Πράξεων ΕΚΤ Αναμόρφωσης Προπτυχιακού Προγράμματος Σπουδών Τμήματος Ιατρικής, ΔΠΘ- ΕΠΕΑΕΚ ΙΙ Πράξεις ΕΤΠΑ για υποστήριξη Πράξεων ΕΚΤ, Υπουργείο Εθνικής Παιδείας και Θρησκευμάτων. Διάρκεια: , Επιστημονικός Υπεύθυνος 4. Μέλος της ομάδας εργασίας του ΔΠΘ στο έργο: «meducator - Multi-type Content Repurposing and Sharing in Medical Education», econtentplus 2008, Information Society and Media Directorate-General, EC, , 5. Μέλος της ομάδας εργασίας ΙntraMEDnet - A Mediterranean Research and Higher Education Intranet in Medical and Biological Sciences ARCHIMED Interreg III, Strand B, ERDF, European Community. Διάρκεια: , Ανάδοχος: Κοινοπραξία Παν. Κύπρου, Νοσ. Πάφου, ΔΠΘ, ΑΠΘ, Παν. Πάτρας, Παν. Νάπολης 6. Υλοποίηση έργου «Πρότυπο σύστημα κατ οίκον υποστήριξης νεφρικής ανεπάρκειας (ΕΠΙΧΕΙΡΗΣΕΙΣ / ΕΦΑΡΜ/0308/66)», Δέσμη Προγραμμάτων για Έρευνα, Τεχνολογική Ανάπτυξη και Καινοτομία Διάρκεια: 014/02/09 έως 31/07/10, Επιστημονικός Υπεύθυνος

4 στην κοινοπραξία. Δημοσιεύσεις σε διεθνή επιστημονικά περιοδικά με αντικείμενο την ιατρική εκπαίδευση 1. E. Kaldoudi, A. Chatzopoulou, V. Vargemezis, Adopting the STARE-HI Guidelines for the Evaluation of Home Care Telehealth Applications: An Interpretive Approach, The Journal on Information Technology in Healthcare 2009; 7(5): E. Kaldoudi, A. Chatzopoulou, V. Vargemezis, An Interpretive Approach in the Evaluation of Homecare Telematics Interventions, PETRA2009: 2nd International Conference on Pervasive Technologies Related to Assistive Environments, Corfu, Greece, June 9-13, E. Kaldoudi, V. Vargemezis, Telecare in Peritoneal Dialysis - Current trends and design considerations,international Workshop on Home telemonitoring, and its status in Cyprus, Greece, and Italy, Thessaloniki, September 1, E. Kaldoudi, P. Passadakis, S. Panagoutsos, V. Vargemezis, Homecare Telematics for Peritoneal Dialysis,Journal on Information Technology in Healthcare, vol. 5(6), pp , E. Kaldoudi, P. Passadakis, S. Panagoutsos, V. Vargemezis, Home Care Telematics for Peritoneal Dialysis: Field Analysis and Design Considerations, ICICTH2007: 5th International Conference on Information & Communication Technologies in Health, Samos, July 5-7, Μ. Papaioakeim, E. Kaldoudi, V. Vargemezis, K. Simopoulos, Confronting the Problem of Ever Expanding Core Knowledge and the Necessity of Handling Overspecialized Disciplines in Medical Education, ITAB 2006: IEEE International Special Topic Conference on Information Technology in Biomedicine, Ioannina, Greece, October 26-28, E. Kaldoudi, V. Vargemezis, K. Simopoulos, Information and Communication Technologies in Medical Undergraduate Education, Journal for Quality of Life Research, vol. 2(1), pp , E. Kaldoudi, V. Vargemezis, Κ. Simopoulos, Information and Communication Technologies in Medical Undergraduate Education, Proceedings of ICICHT 2004: 2nd International Conference on Information Communication Technologies in Health, pp , Samos, Greece, July 8-10, Δημοσιεύσεις ερευνητικού έργου 93 Δημοσιευμένες μελέτες σε ξενόγλωσσα ιατρικά περιοδικά: PubMed - indexed for MEDLINE και SCOPUS 1. Lialiaris T, Mavromatidou P, Digkas E, Passadaki T, Mpountoukas P, Panagoutsos S, Vargemezis V. Chromosome Instability in Patients with Chronic Renal Failure.Genet Test Mol Biomarkers Nov Iordanidou M, Tavridou A, Petridis I, Arvanitidis KI, Christakidis D,Vargemezis V, Manolopoulos VG. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clin Chim Acta. 411 (3-4), pp , 2009 Nov Digkas E, Kareli D, Chrisafi S, Passadaki T, Mantadakis E, Hatzimichail A,Vargemezis V, Lialiaris T. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11). Food Chem Toxicol Oct 9. 48(1), pp Bacharaki D, Thodis E, Passadakis P, Kantartzi K, Kriki P, Vargemezis V. Comparative in vitro Study of Different Peritoneal Dialysis Solutions on Cytokine Production by Peripheral

5 Blood Mononuclear Cells. Nephron Clin Pract Sep 3;113(4):c321-c329. [Epub ahead of print] PubMed PMID: Thodis E, Kriki P, Kakagia D, Passadakis P, Theodoridis M, Mourvati E, Vargemezis V. Rigorous Vibrio vulnificus soft tissue infection of the lower leg in a renal transplant patient managed by vacuum therapy and autologous growth factors. J Cutan Med Surg Jul- Aug;13(4): Vargemezis V, Liakopoulos V, Kriki P, Panagoutsos S, Leontsini M, Passadakis P, Thodis E. Pivotal Role of Paricalcitol in the Treatment of Calcific Uremic Arteriolopathy in the Presence of a Parathyroid Adenoma. Am J Kidney Dis May (1), pp Kriki P, Thodis E, Deftereos S, Panagoutsos S, Theodoridis M, Kantartzi K, Mourvati E, Prassopoulos P, Passadakis P, Vargemezis V. A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient. Clin Nephrol Jun;71(6): Oreopoulos DG, Thodis E, Passadakis P, Vargemezis V. Home dialysis as a first option: a new paradigm. Int Urol Nephrol. 2009;41(3): Epub 2009 May 9. Review. PubMed PMID: Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C. Clinicopathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant Sep;24(9): Epub 2009 Apr 8. PubMed PMID: Kantartzi K, Panagoutsos S, Kokkinou V, Passadakis P, Vargemezis V. Unexpectedly high incidence of brucellosis in one university dialysis unit of North East Greece. Nephrol Dial Transplant Jun;24(6): Epub 2009 Mar 30. PubMed PMID: Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G,McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med Apr 2;360(14): Epub 2009 Mar 30. PubMed PMID: Courcoutsakis N, Souftas V, Thodis I, Vargemezis V, Prassopoulos P. Sclerosing peritonitis. Intern Med. 2008;47(15): Epub 2008 Aug 1. PubMed PMID: Hutchison AJ, Laville M; SPD Lanthanum Study Group. Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden. Nephrol Dial Transplant Nov;23(11): Epub 2008 Jun 24. PubMed PMID: ; PubMed Central PMCID: PMC Aspris AK, Thodi CD, Balatsouras DG, Thodis ED, Vargemezis V, Danielides V. Auditory brainstem responses in patients under treatment of hemodialysis. Ren Fail. 2008;30(4): PubMed PMID:

6 15. Fatouros IG, Pasadakis P, Sovatzidis A, Chatzinikolaou A, Panagoutsos S, Sivridis D, Michailidis I, Douroudos I, Taxildaris K, Vargemezis V. Acute exercise may exacerbate oxidative stress response in hemodialysis patients. Nephron Clin Pract. 2008;109(2):c Epub 2008 Jun 18. PubMed PMID: Georgiadis GS, Lazarides MK, Panagoutsos SA, Kantartzi KM, Lambidis CD, Staramos DN, Vargemezis VA. Surgical revision of complicated false and true vascular access-related aneurysms. J Vasc Surg Jun;47(6): PubMed PMID: cited 1 time 17. Antoniadi G, Eleftheriadis T, Liakopoulos V, Kakasi E, Kartsios C, Passadakis P, Vargemezis V. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial Jun;12(3): PubMed PMID: Kaldoudi, E., Bamidis, P., Papaioakeim, M., Vargemezis, V. Problem-based learning via Web 2.0 technologies (2008) Proceedings - IEEE Symposium on Computer-Based Medical Systems, art. no , pp Cited 3 times. 19. Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Ren Fail. 2008;30(2): PubMed PMID: cited 2 times 20. Iordanidou M, Tavridou A, Vasiliadis MV, Arvanitidis KI, Petridis J, Christakidis D, Vargemezis V, Bougioukas G, Manolopoulos VG. The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenet Genomics Feb;18(2): PubMed PMID: cited 2 times 21. Macdougall, I.C., Walker, R., Provenzano, R., de Alvaro, F., Locay, H.R., Nader, P.C., Locatelli, F., Dougherty, F.C., Beyer, U., Altieri, P., Amato, M., Annerstedt, M., Balducci, A., Barre, P., Breen, C., Brown, E., Burgos-Calderon, R., Carpenito, G., Choukroun, G., Craver, L., Culleton, B., de Alvaro, F., Deferrari, G., del Pino y Pino, M., Dragoun, G.-P., Durand, D., Esnault, V., Evenepoel, P., Faller, B., Fine, A., Fischer, D., Formica, M., Frei, U., Frenken, L., Golper, T., Hagen, C., Hahn, K., Harris, K., Imbasciati, E., Jacquot, C., Jolly, S., Kaysen, G., Kerr, P., Kessler, M., Kopyt, N., Kovesdy, C., Kraut, J., Kwan, J., Lafayette, R., Laville, M., Levin, A., Locatelli, F., Locay, H.R., Lok, C., Macdougall, I.C., MacPhee, I., Franco, J.E.M., Castelao, A.M., McMahon, A., Ruiz, E.M., Muirhead, N., Murphy, S., Nader, P.C., Nassar, G.M., Noble, S., Papadakis, G., Papadakis, I., Penfield, J., Pichette, V., Provenzano, R., Pylypchuk, G., Risler, T., Puyol, D.R., Rosansky, S., Sakellariou, G., Schmidt, R., Siamopoulos, K., Solomon, R., Spinowitz, B., Stegmayr, B., Suranyi, M., Tam, P., Tobe, S., Vargemezis, V., Vela, C., Villa, G., Walker, R., Warr, K., Wijeyesinghe, C., Woitas, R., Zoccali, C. C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: Results of a randomized clinical trial (2008) Clinical Journal of the American Society of Nephrology, 3 (2), pp Cited 9 times 22. Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Am J Kidney Dis Dec;50(6): PubMed PMID: cited 10 times

7 23. Tsouchnikas I, Tsilipakou M, Daniilidis M, Kyriazis G, Pasadakis P, Parapanissiou E, Vargemezis V, Tsakiris D. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving rythropoietin. Nephron Clin Pract. 2007;107(3):c Epub 2007 Sep 21. PubMed PMID: cited 2 times : Patsalas S, Eleftheriadis T, Spaia S, Theodoroglou H, Antoniadi G, Liakopoulos V, Passadakis P, Vayonas G, Vargemezis V. Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calciumphosphorous metabolism? Ren Fail. 2007;29(5): PubMed PMID: cited 2 times 25. Pazarloglou M, Spaia S, Pagkalos E, Ioannidis H, Askepidis N, Varyemezis V. Evaluation of insulin resistance and sodium sensitivity in normotensive offspring of hypertensive individuals. Am J Kidney Dis Apr;49(4): PMID: [PubMed - indexed for MEDLINE] 26. Eleftheriadis T, Liakopoulos V, Antoniadi G, Poultsidi A, Kortsaris A, Stefanidis I, Vargemezis V. No effect of serum parathyroid hormone level on antigen presenting celldependent T-cell reactivity in hemodialysis patients. Int Urol Nephrol. 2007;39(2): Epub 2007 Feb 16. PubMed PMID: cited 1 time 27. Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol. 2007;27(3): Epub 2007 Mar 27. PubMed PMID: cited 5 times 28. Antoniadi G, Eleftheriadis T, Liakopoulos V, Stefanidis I, Vargemezis V. Is there any benefit from oral a-tocopherol administration in hemodialysis patients? Ren Fail. 2007;29(2): PubMed PMID: Patsalas S, Eleftheriadis T, Theodoroglou H, Antoniadi G, Liakopoulos V, Vargemezis V. Coronary artery calcification, coronary artery stenosis and hyperphosphatemia in hemodialysis patients. Ther Apher Dial Feb;11(1):81; author reply 82. PubMed PMID: cited 1 time 30. Eleftheriadis T, Antoniadi G, Liakopoulos V, Stefanidis I, Vargemezis V. Can serological tests tell us something about latent tuberculosis in hemodialysis patients? Ther Apher Dial Feb;11(1):78-9; author reply 80. PubMed PMID: cited 1 time 31. Kalaitzis C, Passadakis P, Giannakopoulos S, Panagoutsos S, Mpantis E, Triantafyllidis A, Touloupidis S, Vargemezis V. Urological management of indinavir-associated acute renal failure in HIV-positive patients. Int Urol Nephrol. 2007;39(3): Epub 2006 Dec 19. PubMed PMID: cited 1 time 32. Kaldoudi, E., Passadakis, P., Panagoutsos, S., Vargemezis, V. Homecare telematics for peritoneal dialysis (2007) Journal on Information Technology in Healthcare, 5 (6), pp Cited 2 times. 33. Georgiadis, G.S., Kantartzi, K.M., Vargemezis, V.A., Lazarides, M.K. The history of vascular access in hemodialysis patients: From the early days of Willem J. Kolff to the present

8 (2007) Archives of Hellenic Medicine, 24 (4), pp de Francisco AL, Sulowicz W, Klinger M, Niemczyk S, Vargemezis V, Metivier F, Dougherty FC, Oguey D; BA16260 Study Invesigators. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study. Int J Clin Pract Dec;60(12): Erratum in: Int J Clin Pract Oct;61(10): PubMed PMID: cited 15 times 35. Thodi C, Thodis E, Danielides V, Pasadakis P, Vargemezis V. Hearing in renal failure. Nephrol Dial Transplant Nov;21(11): Epub 2006 Aug 25. Review. PubMed PMID: Thodi-Petrou, C., Thodis, E., Danielides, V., Pasadakis, P., Vargemezis, V. Hearing in renal failure (2006) Nephrology Dialysis Transplantation, 21 (11), pp Cited 5 times. 37. Griveas I, Visvardis G, Sakellariou G, Passadakis P, Thodis I, Vargemezis V, Pavlitou A, Fleva A. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers. Ren Fail. 2006;28(6): PubMed PMID: cited 4 times 38. Verettas DJ, Ververidis AN, Boyiatzis C, Panagoutsos S, Galanis V, Passadakis P, Kazakos K, Vargemezis V. Tuberculous spondylitis in patients with end-stage renal disease undergoing chronic hemodialysis therapy. Clin Nephrol Apr;65(4): PubMed PMID: Eleftheriadis T, Spaia S, Patsalas S, Kortsaris A, Stavrati A, Panou E, Antoniadi G, Passadakis P, Geleris P, Vayonas G, Liakopoulos V, Vargemezis V. Aortic stiffness in patients undergoing hemodialysis is positively related to antigen presenting cell-dependent T- lymphocyte reactivity. Ren Fail. 2006;28(1):63-8. PubMed PMID: Panagoutsos S, Kantartzi K, Passadakis P, Yannatos E, Mourvati E, Theodoridis M, Kriki P, Thodis E, Vargemezis V. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin Nephrol Jan;65(1):43-7. PubMed PMID: cited 8 times 41. Mimidis K, Mourvati E, Kaliontzidou M, Papadopoulos V, Thodis E, Kartalis G, Vargemezis V. Efficacy of polyethylene glycol in constipated CAPD patients. Perit Dial Int Nov-Dec;25(6): PubMed PMID: Theodoridis M, Passadakis P, Kriki P, Panagoutsos S, Yannatos E, Kantartzi K, Sivridis D, Vargemezis V. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients. Perit Dial Int Nov-Dec;25(6): PubMed PMID: cited 8 times 43. Patsalas S, Eleftheriadis T, Spaia S, Theodoroglou H, Panou E, Liakopoulos V, Antoniadi G, Passadakis P, Vayonas G, Kanakis E, Vargemezis V. The value of computed tomographyderived coronary artery calcification score in coronary artery disease detection in asymptomatic hemodialysis patients. Ren Fail. 2005;27(6): PubMed PMID: cited 5 times 44. Eleftheriadis T, Tsiaga P, Antoniadi G, Liakopoulos V, Kortsaris A, Giannatos E, Barbutis

9 K, Stefanidis I, Vargemezis V. The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis Oct;46(4): PubMed PMID: cited 6 times 45. Thodis E, Passadakis P, Lyrantzopooulos N, Panagoutsos S, Vargemezis V, Oreopoulos D. Peritoneal catheters and related infections. Int Urol Nephrol. 2005;37(2): Review. PubMed PMID: cited 6 times 46. Kantartzi K, Passadakis P, Polychronidis A, Perente S, Vargemezis V, Simopoulos C. Prolene hernia system: an innovative method for hernia repair in patients on peritoneal dialysis. Perit Dial Int May-Jun;25(3): PubMed PMID: cited 2 times 47. Kantartzi K, Polychronidis A, Theodoridis M, Perente S, Vargemezis V, Simopoulos C. Laparoscopic cholecystectomy and inguinal hernia repair in a patient on continuous ambulatory peritoneal dialysis. Clin Nephrol Apr;63(4): PubMed PMID: cited 2 times 48. Antoniadi G, Eleftheriadis T, Liakopoulos V, Kakasi E, Vayonas G, Kortsaris A, Vargemezis V. Effect of 1-year oral alpha-tocopherol administration on anticardiolipin antibodies in hemodialysis patients. Ren Fail. 2005;27(2): PubMed PMID: cited 3 times 49. Grzeszczak W, Sulowicz W, Rutkowski B, de Vecchi AF, Scanziani R, Durand PY,Bajo A, Vargemezis V; European Collaborative Group. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia. Nephrol Dial Transplant May;20(5): Epub 2005 Mar 15. PubMed PMID: cited 21 times 50. Georgiadis GS, Lazarides MK, Lambidis CD, Panagoutsos SA, Kostakis AG, Bastounis EA, Vargemezis VA. Use of short PTFE segments (<6 cm) compares favorably with pure autologous repair in failing or thrombosed native arteriovenous fistulas. J Vasc Surg Jan;41(1): Review. PubMed PMID: cited 7 times 51. Vargemezis V, Passadakis P, Liakopoulos V, Kriki P, Kantartzi A. Fungal colonization of peritoneal catheter with persistently sterile cloudy effluent, in the absence of clinical findings of fungal peritonitis. Perit Dial Int Jan-Feb;24(1):81-4. PubMed PMID: cited 1 time 52. Alexopoulos, E., Madias, N.E., Tsakiris, D., Sakellariou, G., Zoubaridis, N., Vlahakos, D., Vargemezis, V., Sombolos, C., Agrafiotis, A., Dimitriadis, A., Stathakis, C., Goumenos, D., Papagianni, A., Koukoudis, P. Treatment of primary IgA nephropathy (2004) Kidney International, 65 (1), pp Cited 14 times. 53. Eleftheriadis T, Papazisis K, Kortsaris A, Vayonas G, Voyatzi S, Vargemezis V. Impaired T cell proliferation and zeta chain phosphorylation after stimulation with staphylococcal enterotoxin-b in hemodialysis patients. Nephron Clin Pract. 2004;96(1):c PubMed PMID: cited 8 times 54. Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos DG. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment. Int J Artif Organs Aug;26(8): Review. PubMed PMID: cited 5 times

10 55. Dimopoulou ID, Kartali SI, Kartalis GN, Manolas KI, Simopoulos KE, Vargemezis BA, Theodoropoulou-Rodiou G, Bowler IC, Crook DW. Relationship between nosocomial Acinetobacter species occurring in two geographical areas (Greece and the UK). J Hosp Infect Jul;54(3): PubMed PMID: Sivridis E, Giatromanolaki A, Touloupidis S, Pasadakis P, Vargemezis V. Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy. Am J Kidney Dis Feb;41(2): PubMed PMID: cited 5 times 57. Malliara M, Passadakis P, Panagoutsos S, Theodoridis M, Thodis E, Bargman J, Jassal V, Vas S, Vargemezis V, Oreopoulos D. Hypotension in patients on chronic peritoneal dialysis: etiology, management, and outcome. Adv Perit Dial.2002;18: PubMed PMID: cited 4 times 58. Fytili CI, Passadakis PS, Progia EG, Kambouromiti GL, Panopoulou MI, Sombolos KI, Vargemezis VA. Is arterial hypertension an underlying factor in the increased serum Lp(a) levels in ESRD dialyzed patients? Ren Fail Sep;24(5): PubMed PMID: cited 2 times 59. Fytili CI, Progia EG, Panagoutsos SA, Thodis ED, Passadakis PS, Sombolos KI, Vargemezis VA. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients. Ren Fail Sep;24(5): PubMed PMID: cited 9 times 60. Panagoutsos SA, Yannatos EV, Passadakis PS, Thodis ED, Galtsidopoulos OG, Vargemezis VA. Effects of hemodialysis dose on anemia, hypertension, and nutrition. Ren Fail Sep;24(5): PubMed PMID: cited 4 times 61. Passadakis P, Malliara M, Thodis E, Vargemezis V, Oreopoulos DG. Arterial hypotension in patients on peritoneal dialysis. Int J Artif Organs Jun;25(6): PubMed PMID: Stathoulopoulou F, Dhillon S, Thodis H, Stathakis C, Vargemezis V. Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients. Nephron May;91(1): PubMed PMID: cited 4 times 63. Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Prevention of catheter related infections in patients on CAPD. Int J Artif Organs Oct;24(10): Review. PubMed PMID: cited 7 times 64. Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Long-term survival with peritoneal dialysis in ESRD due to diabetes. Clin Nephrol Oct;56(4): Review. PubMed PMID: cited 9 times 65. Vargemezis V, Thodis E. Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16 Suppl 6: Review. PubMed PMID: Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Peritoneal dialysis: better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a dialysis modality. Perit Dial Int Jan-Feb;21(1): Review. PubMed PMID: cited

11 24 times 67. Vargemezis, V., Thodis, E. Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis (2001) Nephrology Dialysis Transplantation, 16 (SUPPL. 6),pp Cited 13times. 68. Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial. 2000;16: PubMed PMID: cited 19 times 69. Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Long-term survival on peritoneal dialysis in end-stage renal disease owing to diabetes. Adv Perit Dial. 2000;16: PubMed PMID: cited 2 times 70. Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics. Adv Perit Dial. 2000;16:2-6. PubMed PMID: cited 9 times 71. Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Abysmal prognosis with type 2 diabetes entering dialysis. Nephrol Dial Transplant Aug;15(8): PubMed PMID: cited 3 times 72. Thodis E, Passadakis P, Panagoutsos S, Marinopoulos D, Vargemezis V. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15: PubMed PMID: cited 5 times 73. Passadakis P, Sud K, Dutta A, Singhal M, Pettit J, Chatalalsingh C, Thodis E, Vargemezis V, Oreopoulos D. Bioelectrical impedance analysis in the evaluation of the nutritional status of continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15: PubMed PMID: cited 9 times 74. Euthimiadou A, Thodis E, Passadakis P, Tsalikis D, Kaisas G, Vargemezis V. Nonsurgical implantation of Tenckhoff peritoneal catheters in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial. 1999;15: PubMed PMID: cited 6 times 75. Passadakis P, Panagoutsos S, Thodis E, Tsivara I, Sopassi F, Kartali S, Vargemezis V. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:40-4. PubMed PMID: cited 10 times 76. Passadakis P, Thodis E, Vargemezis V, Oreopoulos G. Recommendations for glucose control in diabetics on CAPD. Int J Artif Organs Oct;22(10): Review. PubMed PMID: cited 4 times 77. Passadakis P, Thodis E, Vargemezis V, Oreopoulos DG. Nutrition in diabetic patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int. 1999;19 Suppl 2:S Review. PubMed PMID: cited 2 times 78. Pasadakis P, Thodis E, Mourvati E, Euthimiadou A, Margaritis D, Manavis J, Vargemezis V. Evaluation of bone mineral density in CAPD patients with dual energy X-ray

12 absorptiometry. Adv Perit Dial. 1996;12: PubMed PMID: cited 9 times 79. Pasadakis P, Thodis E, Manavis J, Mourvati E, Panagoutsos S, Vargemezis V. The identification of bone mineral density in CAPD in comparison with HD patients. Adv Perit Dial. 1995;11: PubMed PMID: cited 5 times 80. Pasadakis P, Thodis E, Eftimimiadou A, Panagoutsos S, Papazoglou D, Kaliengidou M, Kartali S, Vargemezis V. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. Adv Perit Dial. 1993;9: PubMed PMID: cited 7 times 81. Pasadakis P, Thodis E, Euthimiadou A, Panagoutsos S, Oustoglou E, Kartali S, Vargemezis V. Treatment of CAPD peritonitis with clavulanate potentiated ticarcillin. Adv Perit Dial. 1992;8: PubMed PMID: cited 1 time 82. Thodis E, Anninos PA, Pasadakis P, Adamopoulos AV, Panagoutsos S, Vargemezis V. Evaluation of CNS-function in CAPD patients using magnetoencephalography (MEG): comparison with hemodialysis patients. Adv Perit Dial. 1992;8: PubMed PMID: Vargemezis V, Thodis E, Pasadakis P, Martinis G, Kousta E. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD. Adv Perit Dial. 1990;6: PubMed PMID: Vargemezis V, Pasadakis P, Thodis E. Effect of a calcium antagonist (verapamil) on the permeability of the peritoneal membrane in patients on continuous ambulatory peritoneal dialysis. Blood Purif. 1989;7(6): PubMed PMID: cited 3 times 85. Vargemezis V, Pasadakis P, Thodis E. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD. Adv Perit Dial. 1989;5:8-11. PubMed PMID: cited 4 times 86. Vargemezis V, Pasadakis P, Thodis H, Coucudis P, Peihaberis P, Jafer H, Jara F, Kartali S. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Adv Perit Dial. 1989;5: PubMed PMID: cited 1 time 87. Vargemezis V, Papadopoulou* JL, Liamos H, Belechri AM, Natscheh T, Vergoulas G, Antoniadou, R, Kilintzis V and Papadimitriou M. Management of Fungal Peritonitis during Continuous Ambulatory Peritoneal DIialysis (CAPD). Perit Dial Int 6(1): 17-20, 1986 cited 3 times 88. Deligiannis A, Paschalidou E, Sakellariou G, Vargemezis V, Geleris P, Kontopoulos A, Papadimitriou M. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21: PubMed PMID: cited 11 times 89. Vargemezis V, Natscheh T, Belechri AM, Tsobanelis T, Eustratiadis G, Papadimitriou M. Pseudomonas peritonitis in patients on CAPD. Life Support Syst Oct-Dec;2(4): PubMed PMID: Papadimitriou, M., Alexopoulos, E., Vargemezis, V.The effect of preventive administration of verapamil on acute ischemic renal failure in dogs (1984) Transplantation

13 Proceedings, 16 (1), pp Cited 2 times. 91. Papadimitriou M, Alexopoulos E, Vargemezis V, Sakellariou G, Kosmidou I, Metaxas P. The effect of preventive administration of verapamil on acute ischaemic renal failure in dogs. Proc Eur Dial Transplant Assoc. 1983;20: PubMed PMID: cited 1 time 92. Deligiannis A, Vargemezis V, Tsobanelis H, Karayiannis A, Kontopoulos A, Papadimitriou M. The acute effect of peritoneal dialysis fluid on left ventricular function in patients on CAPD. Life Support Syst. 1983;1 Suppl 1: PubMed PMID: Sakellariou, G., Bourikas, G., Vargemezis, V., Papadimitriou, M. Multiple myeloma presented as chronic renal failure (1982) Chemioterapi